December 2009 Action Date for Schering-Plough HealthCare Products's OTC ZEGERID New Drug Application
6/23/2009 11:56:12 AM
More...
|
Santarus Inc. (SNTS) Announces Schering-Plough HealthCare Products Response Submission to FDA for OTC ZEGERID
6/9/2009 9:18:31 AM
More...
|
Santarus Inc. (SNTS) Achieves $2.5 Million Regulatory Milestone Under OTC License Agreement with Schering-Plough HealthCare Products
5/27/2008 10:25:34 AM
More...
|
Santarus Inc. (SNTS) Announces Submission of New Drug Application by Schering-Plough HealthCare Products for ZEGERID Branded OTC Product
3/11/2008 9:30:59 AM
More...
|
Santarus Inc. (SNTS) Announces Effective Date Of OTC License Agreement With Schering-Plough HealthCare Products; Santarus Expects To Receive $15 Million
11/21/2006 9:03:23 AM
More...
|
Schering-Plough Corporation (SGP) Schedules Conference Call And Webcast For First Quarter 2005 Earnings
10/19/2005 5:13:05 PM
More...
|
Schering-Plough Corporation (SGP) Release: FDA Approves TEMODAR(R) (temozolomide) As Treatment For Patients With Newly Diagnosed Glioblastoma Multiforme
10/19/2005 5:13:02 PM
More...
|
Schering-Plough Corporation (SGP) Appoints Guy Fekete General Manager, Animal Health, France
10/19/2005 5:12:51 PM
More...
|
Schering-Plough Corporation (SGP) Appoints Urban Widen As General Manager, Sweden
10/19/2005 5:12:50 PM
More...
|
Schering-Plough Corporation (SGP) Appoints Ted Lithgow, Ph.D., Group Vice President, Commercial Development
10/19/2005 5:12:27 PM
More...
|
|